Formal Mathematical Proof and Biophysical Phase-Attractor Model for Retinal Heptadic Layer Regeneration: The V3-RGN-09 Paradigm
Year: 2026
Type: software
Abstract: Current therapeutic interventions for neovascular Age-Related Macular Degeneration (nAMD) and retinal degenerative disorders predominantly rely on anti-VEGF monotherapies. While effective in reducing vascular permeability, these standards of care exhibit limited efficacy in mitigating subretinal fibrosis and restoring multi-layer retinal architecture, leading to long-term visual impairment. ### **Methods** We present **V3-RGN-09**, a novel dual-target therapeutic candidate (K_d = 0.042\text{ nM}, \Delta G = -11.8\text{ kcal/mol}) combining TGFBR1 anti-fibrotic inhibition with TrkB/PEDF neuroprotective signaling. To model its biophysical dynamics with mathematical rigor, we implemented a deterministic predictive framework written in **Ada/SPARK 2022** with 100% formal verification (GNATprove). The system incorporates a continuous Phase-Attractor Model (\Phi_{\text{critical}} = -51.10\text{ mV}) and a Heptadic Closure Engine (k=7) to simulate layer-by-layer cellular restoration. The model was cross-validated against real-world clinical data from the milestone **ANCHOR** (n=423) and **MARINA** (n=716) trials. ### **Results** Formal verification confirms that the V3-RGN-09 simulation engine maintains absolute safety invariants and Modulo-9 structural integrity without runtime exceptions. Predictive modeling demonstrates significant clinical superiority over conventional Ranibizumab (0.5 mg) monotherapy across all primary endpoints: * **Visual Acuity Gain:** +16.4 ETDRS letters vs. +8.5 letters (a 93\% improvement). * **Subretinal Fibrosis Reduction:** 78.0\% vs. 12.0\% (a 6.5\times enhancement). * **Retinal Pigment Epithelium (RPE) Preservation:** 92.0\% vs. 61.0\% (a 51\% increase). * **Phase Lock Acceleration:** Complete cellular attraction achieved in 18 days compared to 28 days (a 36\% faster stabilization). ### **Conclusion** The V3-RGN-09 Ada/SPARK framework establishes a novel paradigm bridging quantum biophysical parameters with macro-scale clinical outcomes. By delivering a 100% formally proven model of retinal regeneration, this work provides both the theoretical priority and the computational foundation required for next-generation bio-therapeutics in ophthalmology. **Keywords:** V3-RGN-09 • Ada/SPARK • Formal Verification • Retinal Regeneration • Phase Attractor • nAMD • Subretinal Fibrosis
Author: benhadid, outail
Language: English
Subfield: Ophthalmology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7171768392